{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:14:01Z","timestamp":1791054841206,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.antiviral.2007.10.005","type":"journal-article","created":{"date-parts":[[2007,11,29]],"date-time":"2007-11-29T18:09:20Z","timestamp":1196359760000},"page":"140-149","source":"Crossref","is-referenced-by-count":52,"title":["Does antiviral therapy have a role in the control of Japanese encephalitis?"],"prefix":"10.1016","volume":"78","author":[{"given":"E.A.","family":"Gould","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2007.10.005_bib1","unstructured":"Acambis, 2007. Acambis ChimeriVax\u2122-JE: a single-dose JE vaccine for endemic markets and travellers. www.acambis.co.uk\/default.asp?id=936."},{"key":"10.1016\/j.antiviral.2007.10.005_bib2","doi-asserted-by":"crossref","first-page":"12925","DOI":"10.1128\/JVI.76.24.12925-12933.2002","article-title":"RNA silencing of dengue virus type 2 replication in transformed C6\/36 mosquito cells transcribing an inverted-repeat RNA derived from the virus genome","volume":"76","author":"Adelman","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3201\/eid0801.010252","article-title":"Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro","volume":"8","author":"Anderson","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/sj.mt.6300231","article-title":"DNAzyme-mediated Inhibition of Japanese encephalitis virus replication in mouse brain","volume":"9","author":"Appaiahgari","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2007.10.005_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/biol.1997.0057","article-title":"Japanese encephalitis and dengue vaccines","volume":"25","author":"Barrett","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.antiviral.2007.10.005_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4269\/ajtmh.1975.24.974","article-title":"The virulence to man of Japanese encephalitis virus in Thailand","volume":"24","author":"Benenson","year":"1975","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.005_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<901::AID-CNCR15>3.0.CO;2-Z","article-title":"Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis","volume":"83","author":"Benvegnu","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.antiviral.2007.10.005_bib9","doi-asserted-by":"crossref","first-page":"12828","DOI":"10.1128\/JVI.79.20.12828-12839.2005","article-title":"Inhibition of Interferon-Stimulated JAK-STAT Signaling by a Tick-Borne Flavivirus and Identification of NS5 as an Interferon Antagonist","volume":"79","author":"Best","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib10","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1046\/j.1432-1033.2003.03540.x","article-title":"Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase\/helicase activities of hepatitis C and related viruses","volume":"270","author":"Borowski","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.antiviral.2007.10.005_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<259::AID-JMV13>3.0.CO;2-M","article-title":"Immunisation with gamma globulin to murray valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against australian encephalitis: evaluation in a mouse model","volume":"61","author":"Broom","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4269\/ajtmh.1959.8.719","article-title":"Ecologic studies of Japanese encephalitis virus in Japan. IX. Epidemiologic correlations and conclusions","volume":"8","author":"Buescher","year":"1959","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.005_bib13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4269\/ajtmh.1959.8.678","article-title":"Ecologic studies of Japanese encephalitis virus in Japan. IV. Avian infection","volume":"8","author":"Buescher","year":"1959","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.005_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4269\/ajtmh.1959.8.651","article-title":"Ecologic studies of Japanese encephalitis virus in Japan. II. Mosquito infection","volume":"8","author":"Buescher","year":"1959","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.005_bib15","first-page":"1043","article-title":"Flaviviruses","volume":"vol. 1","author":"Burke","year":"2001"},{"key":"10.1016\/j.antiviral.2007.10.005_bib16","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1086\/509644","article-title":"Role of intravenous immunoglobulin administration in Japanese encephalitis","volume":"43","author":"Caramello","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib17","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1099\/vir.0.81123-0","article-title":"Antiviral effect of dehydroepiandrosterone on Japanese encephalitis virus infection","volume":"86","author":"Chang","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib18","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bbrc.2005.03.107","article-title":"Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites","volume":"330","author":"Chanprapaph","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2007.10.005_bib19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/infdis\/141.6.712","article-title":"Transplacental infection with Japanese encephalitis virus","volume":"141","author":"Chaturvedi","year":"1980","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2007.10.005_bib20","first-page":"49","article-title":"Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C","volume":"19","author":"Davis","year":"1999","journal-title":"Semin. Liver Dis."},{"issue":"Suppl 1","key":"10.1016\/j.antiviral.2007.10.005_bib21","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/0168-8278(90)90160-S","article-title":"Treatment of chronic hepatitis C with recombinant alpha-interferon. A multi-centre randomized, controlled trial. The Hepatitis Interventional Therapy Group","volume":"11","author":"Davis","year":"1990","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib22","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1099\/0022-1317-83-10-2443","article-title":"Genome sequence analysis of Tamana bat virus and its relationship with the genus Flavivirus","volume":"83","author":"de Lamballerie","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib23","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1128\/JVI.79.8.4599-4609.2005","article-title":"Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication","volume":"79","author":"Deas","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib24","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/AAC.00069-07","article-title":"In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus","volume":"51","author":"Deas","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.10.005_bib25","first-page":"4","article-title":"Virus isolation from wild-caught mosquitoes during a Japanese encephalitis outbreak in Kerala in 1996","volume":"106","author":"Dhanda","year":"1997","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.antiviral.2007.10.005_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/viro.2002.1685","article-title":"Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA","volume":"304","author":"Diamond","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.10.005_bib27","first-page":"11","article-title":"Japanese encephalitis virus: ecology and epidemiology","volume":"267","author":"Endy","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/138161206776361147","article-title":"Understanding Helicases as a Means of Virus Control","volume":"12","author":"Frick","year":"2006","journal-title":"Curr. Pharm. Design."},{"key":"10.1016\/j.antiviral.2007.10.005_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.27.3.309","article-title":"Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A\/Victoria\/7\/83 (H1N1) and B\/Texas\/1\/84","volume":"27","author":"Gilbert","year":"1985","journal-title":"Antimicrob. Agents Ch."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2007.10.005_bib30","first-page":"35","article-title":"Standards of treatment in chronic hepatitis C","volume":"19","author":"Gish","year":"1999","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0166-3542(99)00023-6","article-title":"Summary of the first international symposium on viral hepatitis","volume":"42","author":"Gonzalez-Peralta","year":"1999","journal-title":"Antivir. Res."},{"issue":"Pt 3","key":"10.1016\/j.antiviral.2007.10.005_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/0022-1317-67-3-591","article-title":"Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice","volume":"67","author":"Gould","year":"1986","journal-title":"J. Gen. Virol."},{"issue":"Pt 12","key":"10.1016\/j.antiviral.2007.10.005_bib33","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1099\/0022-1317-68-12-3105","article-title":"Immune enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms involved","volume":"68","author":"Gould","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib34","first-page":"65","article-title":"Evolution and dispersal of encephalitic flaviviruses","volume":"18","author":"Gould","year":"2004","journal-title":"Arch. Virol. Suppl."},{"key":"10.1016\/j.antiviral.2007.10.005_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0065-3527(06)69005-2","article-title":"Origin and evolution of 3\u2019UTR of flaviviruses: long direct repeats as a basis for the formation of secondary structures and their significance for virus transmission","volume":"69","author":"Gritsun","year":"2007","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.antiviral.2007.10.005_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2007.04.011","article-title":"Origin and evolution of flavivirus 5\u2019UTRs and panhandles; trans-terminal duplications?","volume":"366","author":"Gritsun","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.10.005_bib37","first-page":"190","article-title":"Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea","volume":"75","author":"Halstead","year":"1962","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.005_bib38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5694\/j.1326-5377.1999.tb127878.x","article-title":"Japanese encephalitis in north Queensland, Australia, 1998","volume":"170","author":"Hanna","year":"1999","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.antiviral.2007.10.005_bib39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/j.1326-5377.1996.tb124960.x","article-title":"An outbreak of Japanese encephalitis in the Torres Strait, Australia 1995","volume":"165","author":"Hanna","year":"1996","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.antiviral.2007.10.005_bib40","first-page":"332","article-title":"The effect of interferon-alpha A on two cases of Japanese encephalitis in Thailand SE Asian","volume":"16","author":"Harinasuta","year":"1985","journal-title":"J. Trop. Med. Public Health"},{"key":"10.1016\/j.antiviral.2007.10.005_bib41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/infdis\/165.4.631","article-title":"Effect of high dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus","volume":"165","author":"Hoke","year":"1992","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2007.10.005_bib42","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1016\/j.antiviral.2007.10.005_bib43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.26.4.476","article-title":"Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses","volume":"26","author":"Huggins","year":"1984","journal-title":"Antimicrob. Agents Ch."},{"key":"10.1016\/j.antiviral.2007.10.005_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/infdis\/153.3.489","article-title":"Ribavirin therapy for Hantaan virus infection in suckling mice","volume":"153","author":"Huggins","year":"1986","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib45","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/infdis\/164.6.1119","article-title":"Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome","volume":"164","author":"Huggins","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib46","first-page":"139","article-title":"Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control","volume":"267","author":"Igarashi","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1348-0421.1994.tb01866.x","article-title":"Detection of West Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan","volume":"38","author":"Igarashi","year":"1994","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4269\/ajtmh.2000.62.631","article-title":"Isolation of Japanese encephalitis virus from mosquitoes (Diptera: Culicidae) collected in the Western Province of Papua New Guinea 1997\u20131998","volume":"62","author":"Johansen","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.005_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcv.2004.03.011","article-title":"Japanese encephalitis virus (JEV) is an important cause of encephalitis among children in Cuddalore district, Tamil Nadu, India","volume":"31","author":"Kabilan","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib50","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","article-title":"Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies","volume":"141","author":"Kimura Kuroda","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib51","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1128\/JVI.79.8.5116-5128.2005","article-title":"Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers","volume":"79","author":"Kinney","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/AAC.24.1.134","article-title":"Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin","volume":"24","author":"Koff","year":"1983","journal-title":"Antimicrob. Agents Ch."},{"key":"10.1016\/j.antiviral.2007.10.005_bib53","doi-asserted-by":"crossref","first-page":"0505","DOI":"10.1371\/journal.pmed.0030096","article-title":"A single siRNA suppresses fatal encephalitis induced by two different flaviviruses","volume":"3","author":"Kumar","year":"2006","journal-title":"PLos Med."},{"key":"10.1016\/j.antiviral.2007.10.005_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2007.10.005_bib55","first-page":"665","article-title":"Zur Wirksamkeit von FSME-immunglobulin","volume":"93","author":"Kunz","year":"1981","journal-title":"Wien. Klein. Wochenschr."},{"key":"10.1016\/j.antiviral.2007.10.005_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3201\/eid1103.040285","article-title":"Japanese encephalitis virus in meningitis patients, Japan","volume":"11","author":"Kuwayama","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib57","unstructured":"LaColla, P., Sommadossi, J.-P., 2004. US6812219."},{"key":"10.1016\/j.antiviral.2007.10.005_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/514059","article-title":"Effect of interferon-alpha and ribavirin therapy on serum GBV virus C\/hepatitis G virus (GBV-C\/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C\/HGV","volume":"176","author":"Lau","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib59","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/viro.2000.0723","article-title":"A novel model for the study of the therapy of flavivirus infections using the Modoc virus","volume":"279","author":"Leyssen","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.10.005_bib61","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/JVI.73.10.8798-8807.1999","article-title":"Structure-based mutagenesis study of hepatitis C virus NS3 helicase","volume":"73","author":"Lin","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2007.10.005_bib63","doi-asserted-by":"crossref","first-page":"12225","DOI":"10.1128\/JVI.78.22.12225-12235.2004","article-title":"Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription","volume":"78","author":"Liu","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib64","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0264-410X(02)00743-0","article-title":"Cross-protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplex","volume":"21","author":"Lobigs","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2007.10.005_bib65","doi-asserted-by":"crossref","unstructured":"Lopez Labrador, F.X., Ampurdanes, S., Gimenez, B., M., Guilera, M., Costa, J., de Anta, M.T.J., Sanchez Tapiaz, J.M., Rodes, J., Saiz, J.C., 1999. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to inteferon in patients with chronic HCV genotype 1b. Hepatology 29, 897\u2013903.","DOI":"10.1002\/hep.510290306"},{"key":"10.1016\/j.antiviral.2007.10.005_bib66","unstructured":"Mackenzie, J., 1997. Emerging viral diseases: an Australian and Papua New Guinean perspective. In: 33rd Annual symposium of the Medical Society of Papua New Guinea, p 12 Goroka."},{"key":"10.1016\/j.antiviral.2007.10.005_bib67","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/13550280591002487","article-title":"Emerging zoonotic encephalitis viruses: lessons from Southeast Asia and Oceania","volume":"11","author":"Mackenzie","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib68","first-page":"1","article-title":"The Japanese encephalitis serological group of flaviviruses: a brief introduction to the group","volume":"vol. 267","author":"Mackenzie","year":"2002"},{"key":"10.1016\/j.antiviral.2007.10.005_bib69","first-page":"49","article-title":"Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia","volume":"267","author":"Mackenzie","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.antiviral.2007.10.005_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-7069(06)16010-3","article-title":"Japanese encephalitis virus: the geographic distribution incidence and spread of a virus with a propensity to emerge in new areas","volume":"16","author":"Mackenzie","year":"2007","journal-title":"Perspect. Med. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-3542(90)90029-7","article-title":"Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys","volume":"13","author":"Malinoski","year":"1990","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.005_bib72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2007.10.005_bib73","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0042-6822(03)00341-6","article-title":"The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses","volume":"313","author":"McCown","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib74","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2007.10.005_bib75","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1074\/jbc.M305041200","article-title":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro","volume":"278","author":"Migliaccio","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.10.005_bib76","first-page":"135","article-title":"Uber den Infektionsmodus der japanischen epidemischen Enzephalitis mit besonderer Berucksichtigung der experimentellen und epidemiologischen Beweise fur die Krankheitsiibertragung durch Mucken","volume":"28","author":"Mitamura","year":"1938","journal-title":"Transactiones Societatis Pathologicae Japonicae"},{"key":"10.1016\/j.antiviral.2007.10.005_bib77","first-page":"105","article-title":"Japanese encephalitis vaccines: current vaccines and future prospects","volume":"267","author":"Monath","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib78","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-3542(02)00013-X","article-title":"Identification of active antiviral compounds against a New York isolate of West Nile virus","volume":"55","author":"Morrey","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.005_bib79","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/bc034221g","article-title":"Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides","volume":"15","author":"Moulton","year":"2004","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.antiviral.2007.10.005_bib80","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of Alpha\/Beta Interferon Signaling by the NS4B Protein of Flaviviruses","volume":"79","author":"Mu\u00f1oz-Jord\u00e1n","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib81","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1348-0421.2005.tb03701.x","article-title":"Inhibitory effect of RNAi on Japanese encephalitis virus replication in vitro and in vivo","volume":"49","author":"Murakami","year":"2005","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000073864","article-title":"Beneficial effect of steroid pulse therapy on acute viral encephalitis","volume":"50","author":"Nakano","year":"2003","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib83","doi-asserted-by":"crossref","first-page":"4853548542","DOI":"10.1074\/jbc.M406810200","article-title":"Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease","volume":"279","author":"Nall","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.10.005_bib84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1014077719162","article-title":"High level of sequence variation in the 3\u2019 noncoding region of Japanese encephalitis viruses isolated in Korea","volume":"24","author":"Nam","year":"2002","journal-title":"Virus Genes"},{"key":"10.1016\/j.antiviral.2007.10.005_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-3542(96)89697-5","article-title":"Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections","volume":"30","author":"Neyts","year":"1996","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.005_bib86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0163-4453(96)91281-5","article-title":"Adverse reactions to Japanese encephalitis vaccine in travelers","volume":"32","author":"Nothdurft","year":"1996","journal-title":"J. Infection"},{"key":"10.1016\/j.antiviral.2007.10.005_bib87","doi-asserted-by":"crossref","unstructured":"Okabe, N., Background of recent JE vaccine issues. Uirusu 55.2005.","DOI":"10.2222\/jsv.55.303"},{"key":"10.1016\/j.antiviral.2007.10.005_bib88","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile Virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2007.10.005_bib89","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.48.10.3944-3953.2004","article-title":"A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties","volume":"48","author":"Olsen","year":"2004","journal-title":"Antimicrob. Agents Ch."},{"key":"10.1016\/j.antiviral.2007.10.005_bib90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(03)00175-X","article-title":"In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111strain) and dengue 1 virus (Hawaii strain)","volume":"60","author":"Ono","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.005_bib91","unstructured":"PATH, 2006. Historic protection for Asia's children: PATH and our partners take action to eliminate Japanese encephalitis. www.pathorg\/projects\/japanese_encephalitis_projectphp."},{"key":"10.1016\/j.antiviral.2007.10.005_bib92","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1128\/JVI.72.4.2795-2805.1998","article-title":"Interferon resistance to of hepatitis C virus genotype 1b: relationship to nonstructural NS5 gene quasispecies mutations","volume":"72","author":"Pawlotsky","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib93","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0168-8278(98)80006-8","article-title":"Predictors of sustained response to alpha interferon therapy in chronic hepatitis C","volume":"29","author":"Peignoux","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib94","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0140-6736(05)66156-9","article-title":"Neurological complications and Japanese encephalitis vaccination","volume":"348","author":"Plesner","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2007.10.005_bib95","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/viro.1996.0213","article-title":"Molecular characterization of the Japanese encephalitis serocomplex of the flavivirus genus","volume":"218","author":"Poidinger","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.10.005_bib96","first-page":"905","article-title":"An epidemic of encephalitis in Haryana: serological evidence of Japanese encephalitis in a few patients","volume":"30","author":"Prasad","year":"1993","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.antiviral.2007.10.005_bib97","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/423325","article-title":"Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis clinical and laboratory results of a pilot study","volume":"190","author":"Rahal","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/157489106775244055","article-title":"Recent advances in flavivirus antiviral drug discovery and vaccine development","volume":"1","author":"Ray","year":"2006","journal-title":"Recent Patents Anti-Infect. Drug Discov."},{"key":"10.1016\/j.antiviral.2007.10.005_bib99","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2007.10.005_bib100","first-page":"281","article-title":"HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV\/HGBV-C","volume":"18","author":"Rostaing","year":"1997","journal-title":"Nephrologie"},{"key":"10.1016\/j.antiviral.2007.10.005_bib101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/095632020301400204","article-title":"Inhibition of Japanese encephalitis virus infection by diethyldithiocarbamate is independent of its antioxidant potential","volume":"14","author":"Saxena","year":"2003","journal-title":"Antivir. Chem. Chemoth."},{"key":"10.1016\/j.antiviral.2007.10.005_bib102","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1017\/S031716710005383X","article-title":"Calgary experience with West Nile virus neurological syndrome during the late summer of 2003","volume":"31","author":"Sayao","year":"2004","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.antiviral.2007.10.005_bib103","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4269\/ajtmh.2004.71.306","article-title":"Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease","volume":"71","author":"Sbrana","year":"2004","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.antiviral.2007.10.005_bib104","first-page":"CD004263","article-title":"Vaccines for preventing Japanese encephalitis","volume":"18","author":"Schi\u00f8ler","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.antiviral.2007.10.005_bib105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0166-3542(03)00009-3","article-title":"Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates","volume":"58","author":"Shigeta","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.005_bib106","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3201\/eid0704.010432","article-title":"Treatment of West Nile virus encephalitis with intravenous immunoglobulin","volume":"7","author":"Shimoni","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib107","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/341247","article-title":"Japanese encephalitis vaccine for travelers: exploring the limits of risk","volume":"35","author":"Shlim","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib108","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0092-8674(00)81275-1","article-title":"Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid","volume":"85","author":"Sintchak","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2007.10.005_bib109","series-title":"Pathogenesis and Clinical Features of Japanese Encephalitis and West Nile Virus Infections","author":"Solomon","year":"2002"},{"key":"10.1016\/j.antiviral.2007.10.005_bib110","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(97)07509-0","article-title":"Poliomyelitis-like illness due to Japanese encephalitis virus","volume":"351","author":"Solomon","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2007.10.005_bib111","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Neurological aspects of tropical disease: Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.antiviral.2007.10.005_bib112","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/brain\/awf116","article-title":"Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis","volume":"125","author":"Solomon","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.antiviral.2007.10.005_bib113","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(03)12709-2","article-title":"Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial","volume":"361","author":"Solomon","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2007.10.005_bib114","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese encephalitis virus in southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib115","unstructured":"Stamos, D.P., Bethiel, R.S., 2004. US6825224."},{"key":"10.1016\/j.antiviral.2007.10.005_bib116","unstructured":"Stein, D.A., Skilling, D.E., Iverson, P.L., Smith, A.W., 2004. US6828105."},{"key":"10.1016\/j.antiviral.2007.10.005_bib117","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/136.1.122","article-title":"Effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta)","volume":"136","author":"Stephen","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.005_bib118","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.1.1997.7.187","article-title":"Morpholino antisense oligomers: design, preparation, and properties","volume":"7","author":"Summerton","year":"1997","journal-title":"Antisense Nucleic A."},{"key":"10.1016\/j.antiviral.2007.10.005_bib119","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.72.5.613","article-title":"Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants","volume":"72","author":"Taber","year":"1983","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2007.10.005_bib120","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2007.10.005_bib121","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2005.02.001","article-title":"The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cells","volume":"66","author":"Talarico","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.005_bib122","series-title":"Virus Taxonomy: VIIIth Report of the ICTV","first-page":"981","article-title":"Flaviviridae","author":"Thiel","year":"2005"},{"key":"10.1016\/j.antiviral.2007.10.005_bib123","doi-asserted-by":"crossref","unstructured":"Tsai, T.F., 2000. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO\/CVI meeting, Bangkok, Thailand, 13\u201315 October 1998; Vaccine 18 (Suppl 2) 1\u201325.","DOI":"10.1016\/S0264-410X(00)00037-2"},{"key":"10.1016\/j.antiviral.2007.10.005_bib124","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1099\/vir.0.18660-0","article-title":"The extent of homologous recombination in members of the genus Flavivirus","volume":"84","author":"Twiddy","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2007.10.005_bib125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4269\/ajtmh.2001.65.242","article-title":"Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering and multiple introductions of the virus into the Indian subcontinent","volume":"65","author":"Uchil","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.005_bib126","first-page":"625","article-title":"Japanese encephalitis: current worldwide status","volume":"63","author":"Umenai","year":"1985","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.antiviral.2007.10.005_bib127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: Prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidem. Rev."},{"key":"10.1016\/j.antiviral.2007.10.005_bib128","first-page":"27","article-title":"The effect of interferon on flaviviruses in vitro: a preliminary study","volume":"15","author":"Vithanomsat","year":"1984","journal-title":"SEAsian J. Trop. Med. Public Health."},{"key":"10.1016\/j.antiviral.2007.10.005_bib129","first-page":"242","article-title":"Global AdvisoryCommittee onVaccine Safety","volume":"80","author":"WHO.","year":"2005","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2007.10.005_bib130","first-page":"337","article-title":"Japanese encephalitis vaccines. WHO position paper","volume":"73","author":"WHO","year":"1998","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2007.10.005_bib131","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(95)92990-8","article-title":"Japanese encephalitis after a 10-day holiday in Bali","volume":"345","author":"Wittesj\u00f6","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2007.10.005_bib132","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1023\/A:1018824311722","article-title":"Hepatitis G and C viruses respond to interferon-alpha with different virologic kinetics","volume":"43","author":"Yang","year":"1998","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.antiviral.2007.10.005_bib133","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1021\/jm030842j","article-title":"Ring-expanded nucleoside and nucleotide (REN) analogues exhibit potent in vitro activity against flaviviridae NTPases\/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus","volume":"46","author":"Zhang","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2007.10.005_bib134","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1021\/jm030277k","article-title":"Potent inhibition of NTPase\/helicase of the West Nile Virus by ring-expanded (\u201cfat\u201d) nucleoside analogues.","volume":"46","author":"Zhang","year":"2003","journal-title":"J. Med. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207004378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207004378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T01:01:49Z","timestamp":1737594109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354207004378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0166354207004378"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.10.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}